Copay Assistance – Good For Patients, Bad For Prices
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
Peter Bach and I have an essay in the Annals of Internal Medicine laying out some of the problems with pharmaceutical funded copay assistance programs. Check it out.
“Is Information Always A Good Thing?” – Medical Care
Russell Wilson took a hard hit to the head in the NFC Championship game last year against the Green Bay Packers. His team, the Seattle Seahawks, won the game, but would Wilson, the team’s star quarterback, recover in time for the next game? That game, by the way, goes by the name The Super Bowl….
David Blumenthal and colleagues recently wrote a wonderful piece in the New England Journal on the future of Medicare. In it, they present a powerful picture comparing how often people in 11 countries have difficulty accessing medical care because of costs. The good news? The USA came in first place. The bad news? First is…
Obamacare dramatically reduced the number of people in United States who lack health insurance. Reduced as in: brought the proportion down to historical lows. Yet very few Americans knew this about the law, which is part of the reason why so many people didn’t like Obamacare. Here’s evidence to back up that connection, from the…
Here is a quick review from the Commonwealth Fund showing what happened to jobs in the United States since 2000. A dramatic growth in healthcare jobs, and almost no growth in the rest of the economy: Something to keep in mind, because if we ever get healthcare costs under control, we had better hope to…
About one in fifty people reading this essay will be diagnosed with kidney cancer at some time in their life. In fact, one out of one people writing this essay has already been diagnosed with kidney cancer. (I had a small tumor removed from my left kidney not long after I turned 50.) But how many people…